About this trial
The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.
Eligibility criteria
Qualifiers
prescription of HFNO by clinician
parent consenting to the use of the data
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Epicentre
Lead sponsor
MOH Afghanistan
Collaborator
MOH Bangladesh
Collaborator
MOH Sierra Leone
Collaborator
MOH Yemen
Collaborator
MSF Médecins Sans Frontières Belgium
Collaborator
MSF Médecins Sans Frontières France
Collaborator
Fisher and Paykel Healthcare
Collaborator